InvestorInvesting in innovative research-based companies with global potential.

Cardeon AB is a publicly listed investment company based in Sweden, focusing on innovative Nordic startups in the medical technology and life sciences sectors. The firm aims to support companies with the potential to significantly impact global markets.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Cardeon AB, founded in 2018 and based in Lund, Sweden, is a publicly listed investment company that primarily invests in innovative Nordic companies and startups within the fields of medical technology and life sciences. The organization aims to assist in the development of ideas from research results to commercial products, providing investments, financing strategies, and access to a broad network to facilitate collaborations and contribute expertise to board activities. Since November 2022, Cardeon's shares have been listed on the NGM Nordic SME under the ticker CARDEO. The company completed a reverse merger with Tectona Capital AB in June 2022, enhancing its portfolio of Nordic medtech and life science companies.
Cardeon invests in companies with the potential to create significant changes in their respective markets on a global scale. The organization provides investments, financing strategies, and access to a broad network to facilitate collaborations, assist in key recruitments, and contribute expertise to board activities.
Cardeon adds value to its portfolio companies by providing strategic investments, facilitating collaborations, assisting in key recruitments, and contributing expertise to board activities, helping to navigate the path from research to market.
Cardeon AB invests in innovative Nordic companies within the medical technology and life sciences sectors. Target companies should have the potential to create significant changes in their respective markets on a global scale, with a minimum market value of SEK 20 million.
Startups interested in pitching to Cardeon AB can visit their website at cardeon.se for more information on the application process. Specific details on pitch formats or requirements are not disclosed.
Cardeon AB is unique in its focus on transforming research results into commercial products. The firm provides not only capital but also strategic investments, access to a broad network for collaborations, and expertise to assist portfolio companies in navigating their growth paths.
Cardeon AB primarily invests in the Nordic region, particularly Sweden, focusing on innovative startups in healthcare and biotech sectors.
Cardeon AB actively contributes expertise to board activities and assists portfolio companies with key recruitments and collaborations, ensuring they have the necessary support to succeed in their markets.
While specific check sizes are not disclosed, Cardeon AB engages in strategic investments that align with its mission to support innovative companies in the medical technology and life sciences sectors.
Superscout Pro
Is this page right?Reviewed · How the research works